Bulletin
Investor Alert

Denali Therapeutics Inc.

NAS: DNLI

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 27, 2023, 6:16 p.m.

/zigman2/quotes/200043077/composite

$

32.00

Change

+0.53 +1.68%

Volume

Volume 8,205

Quotes are delayed by 20 min

/zigman2/quotes/200043077/composite

Previous close

$ 30.53

$ 31.47

Change

+0.94 +3.08%

Day low

Day high

$30.53

$31.98

Open

52 week low

52 week high

$20.24

$39.43

Open

Annual Financials for Denali Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue -129.16M26.68M335.66M48.66M
Cost of Goods Sold (COGS) incl. D&A 3.08M---5.61M
COGS excluding D&A -----
Depreciation & Amortization Expense 3.08M7.42M7.99M6.17M5.61M
Depreciation 3.08M7.42M7.99M6.17M5.61M
Amortization of Intangibles -----
Gross Income (3.08M)---43.05M
20172018201920202021 5-year trend
SG&A Expense 87.06M160.22M230.37M266.77M338.8M
Research & Development 71.38M135.28M191.88M212.62M265.35M
Other SG&A 15.68M24.93M38.49M54.16M-
Other Operating Expense -----
Unusual Expense -8.1M1.3M(100,000)-
EBIT after Unusual Expense -(46.57M)(212.98M)62.82M-
Non Operating Income/Expense -----
Non-Operating Interest Income 1.96M10.33M15.02M9.14M4.6M
Equity in Affiliates (Pretax) -----
Interest Expense -----
Gross Interest Expense -----
Interest Capitalized -----
Pretax Income (88.19M)(36.24M)(197.97M)71.96M(291.16M)
Income Tax --(351,000)823,000(575,000)
Income Tax - Current Domestic ---823,000(576,000)
Income Tax - Current Foreign ----1,000
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (88.19M)(36.24M)(197.61M)71.14M(290.58M)
Minority Interest Expense -----
Net Income (88.19M)(36.24M)(197.61M)71.14M(290.58M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (88.19M)(36.24M)(197.61M)71.14M(290.58M)
Preferred Dividends -----
Net Income Available to Common (88.19M)(36.24M)(197.61M)71.14M(290.58M)
EPS (Basic) (5.89)(0.39)(2.07)0.65(2.39)
Basic Shares Outstanding 14.96M92.62M95.61M108.97M121.52M
EPS (Diluted) (5.89)(0.39)(2.07)0.63(2.39)
Diluted Shares Outstanding 14.96M92.62M95.61M112.7M121.52M
EBITDA (87.06M)(31.06M)(203.69M)68.89M(290.14M)
Link to MarketWatch's Slice.